US FDA Panel To Meet on Transplant IVDs, Test For Managing Antibiotics

The agency's microbiology devices advisory panel will hold a two-day meeting next month focused on classification of transplant IVDs and potential 510(k) requirements for a test that can help detect and monitor sepsis and other bacterial infection.